Novo Integrated Sciences, Inc. Common Stock
NVOS
NVOS was delisted on the 5th of November, 2024.
14 hedge funds and large institutions have $325K invested in Novo Integrated Sciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
285% more capital invested
Capital invested by funds: $84.5K → $325K (+$241K)
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
1% more ownership
Funds ownership: 0.51% → 1.52% (+1%)
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$108K |
| 2 |
State Street
Boston,
Massachusetts
|
+$36.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$18.8K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$17.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$13.1K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.51K |
| 3 |
Squarepoint
New York
|
-$2.04K |
| 4 |
Goldman Sachs
New York
|
-$1.74K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$1.01K |
NVOS Hedge Fund Activity: Q2 2023 in Review
14 of the 6,385 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q2 2023, worth a combined $325K — up 285% from $84.5K a quarter earlier.
Fund positioning in NVOS was balanced in Q2 2023: 3 funds opened new positions, 3 closed out, 5 added to existing stakes and 3 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $108K. The largest seller was Millennium Management, cutting an estimated $13.1K.
- 14 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $325K of Novo Integrated Sciences, Inc. Common Stock stock for Q2 2023, up 285% quarter-over-quarter.
- 3 funds opened new Novo Integrated Sciences, Inc. Common Stock positions in Q2 2023 and 3 closed out, a net change of 0 holders.
- The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q2 2023 was Geode Capital Management, an estimated $108K added.
- The largest Novo Integrated Sciences, Inc. Common Stock seller in Q2 2023 was Millennium Management, an estimated $13.1K sold.
Based on aggregated 13F filings for Q2 2023.